Literature DB >> 317034

Lymphocyte-mediated cytotoxicity in isoniazid-associated hepatitis.

R J Warrington, S L Olivier.   

Abstract

The release of lymphotoxin (LT) from peripheral blood lymphocytes of patients with isoniazid (INH)-induced hepatitis was studied, using L929 fibroblast target cells, as was the cytotoxic effect of these lymphocytes on murine hepatoma cells (L1469) and L929 fibroblasts, using a 3H-proline cytotoxicity assay. Evidence for LT release was found in five out of six patients, following stimulation of the peripheral blood lymphocytes with INH or isonicotinic acid (INA) conjugated to human serum albumin. In the direct cytotoxicity assay, cytotoxic effects on the hepatoma cells were enhanced by preincubation of the target cells with INH in five out of six patients tested. Although specificity with regard to the drug was demonstrable, tissue specificity was less certain in that enhanced killing of the fibroblast cell line was also found to occur following preincubation of the L929 cells with INH.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 317034      PMCID: PMC1537925     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Fatal hepatic necrosis secondary to isoniazid therapy.

Authors:  R COHEN; M H KALSER; R V THOMSON
Journal:  JAMA       Date:  1961-06-10       Impact factor: 56.272

2.  Toxic hepatic necrosis (hepatitis) due to isoniazid: report of a case with cirrhosis and death due to hemorrhage from esophageal varices.

Authors:  A D MERRITT; B F FETTER
Journal:  Ann Intern Med       Date:  1959-03       Impact factor: 25.391

3.  Icterus and febrile reactions in response to isonicotinic acid hydrazine; report of two cases and review of the literature.

Authors:  E HABER; R K OSBORNE
Journal:  N Engl J Med       Date:  1959-02-26       Impact factor: 91.245

4.  Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.

Authors:  W C Bailey; S L Taylor; H E Dascomb; H B Greenberg; M M Ziskind
Journal:  Am Rev Respir Dis       Date:  1973-04

5.  Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease.

Authors:  A M Cochrane; A Moussouros; B Portmann; I G McFarlane; A D Thomson; R Williams
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

6.  Lymphocyte cytotoxicity against Chang liver cells in chronic active hepatitis.

Authors:  S Kakumu; T Hara; H Goji; N Sakamoto
Journal:  Cell Immunol       Date:  1978-03-01       Impact factor: 4.868

7.  Lymphocyte transformation studies in drug hypersensitivity.

Authors:  R J Warrington; K S Tse
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

8.  Evaluation of isoniazid-associated hepatitis by immunological tests.

Authors:  R J Warrington; K S Tse; B A Gorski; R Schwenk; A H Sehon
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

9.  Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.

Authors:  D E Kopanoff; D E Snider; G J Caras
Journal:  Am Rev Respir Dis       Date:  1978-06

10.  Lymphocyte cytotoxicity in alcoholic hepatitis.

Authors:  S Kakumu; C M Leevy
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

View more
  1 in total

1.  Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin.

Authors:  Imir G Metushi; Jack Uetrecht
Journal:  Mol Cell Biochem       Date:  2013-10-23       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.